ANI Pharmaceuticals Inc (ANIP)

ANI Pharmaceuticals Inc (ANIP) 재무 분석

손익 계산서

분기별

*모든 숫자는 백만 단위입니다.

기간 종료일	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	0.13% 131.65	131.83	116.55	106.79	94.23
Operating Expenses	9.70% 124.93	113.88	104.14	96.89	92.41
Benefits Costs and Expenses	8.63% 130.71	120.32	111.30	104.62	99.96
Costs And Expenses	9.70% 124.93	113.88	104.14	96.89	92.41
Depreciation and Amortization	0.09% 15.19	15.21	14.69	14.70	14.48
Operating Income/Loss	62.53% 6.726	17.95	12.40	9.895	1.82
Income/Loss From Continuing Operations Before Tax	91.77% 0.947	11.51	5.249	2.165	-5.728
Income Tax Expense/Benefit	113.24% -0.208	1.571	-0.996	0.726	-1.485
Income/Loss From Continuing Operations After Tax	88.38% 1.155	9.94	6.245	1.439	-4.243
Net Income/Loss	88.38% 1.155	9.94	6.245	1.439	-4.243
Preferred Stock Dividends And Other Adjustments	0.00% 0.406	0.406	0.407	0.406	0.407
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	98.21% 0.338	18.88	17.69	16.39	0.022
Diluted Average Shares	98.06% 0.371	19.12	17.86	16.53	0.022
Basic Earnings Per Share	95.65% 0.02	0.46	0.30	0.06	-0.29
Diluted Earnings Per Share	95.56% 0.02	0.45	0.29	0.06	-0.29
Undistributed Earnings/Loss Allocated To Participating Securities, Basic	94.39% 0.05	0.891	0.589	0.113	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	64.84% 0.456	1.297	0.996	0.519	0.407